Your digestive system has absorption limits, and once these transporters are saturated, any additional nutrients are simply passed through and excreted
Interference with Chemotherapy : Some studies suggest that glutathione may protect cancer cells from the effects of chemotherapy , potentially reducing the treatment's efficacy
Therefore, to accurately assess the safety and efficacy of topical collagen peptidesparticularly those employing enhanced delivery systemswell-designed, randomized, double-blind, controlled clinical trials in humans are still required
Why women need lower doses Biological differences: Smaller average body size Different hormone profiles More sensitive to some peptides Better response at lower doses often General rule: Start 20-30% lower than male doses Women: 150-200mcg vs Men: 200-300mcg (GH peptides) Titrate based on response More isn't better for women Hormone cycle considerations (perimenopause) If still menstruating: GH peptides: Use consistently throughout cycle Weight loss peptides: May work better in follicular phase (days 1-14) Some women dose higher during luteal phase (more resistant) Track response across full cycle Post-menopause: No cycle to consider Consistent dosing easier More predictable results Age-specific dosing Women 40-50 (perimenopause): Start conservative Body still producing some hormones Lower doses effective Women 50-60 (menopause): Standard doses appropriate Need more GH replacement Can titrate higher if needed Women 60-70+: Start very low Increase slowly More sensitive to side effects Benefits still significant Safety considerations for women over 40 Special precautions for this demographic
Knowing what to expect and how to respond helps you manage your therapy effectively
In essence, while nanoencapsulation holds nutritional promise, a parallel effort is needed to rigorously evaluate and ensure the health safety of these novel delivery systems
